Cofactors and pathogens: Flavin mononucleotide and flavin adenine dinucleotide (FAD) biosynthesis by the FAD synthase from Brucella ovis.
FMN:adenylyltransferase
enzyme kinetics
enzyme species-specific traits
flavin biosynthesis
kinetics limiting steps
riboflavin kinase
Journal
IUBMB life
ISSN: 1521-6551
Titre abrégé: IUBMB Life
Pays: England
ID NLM: 100888706
Informations de publication
Date de publication:
07 2022
07 2022
Historique:
revised:
14
10
2021
received:
22
09
2021
accepted:
26
10
2021
pubmed:
24
11
2021
medline:
1
7
2022
entrez:
23
11
2021
Statut:
ppublish
Résumé
The biosynthesis of the flavin mononucleotide (FMN) and flavin adenine dinucleotide (FAD), cofactors used by 2% of proteins, occurs through the sequential action of two ubiquitous activities: a riboflavinkinase (RFK) that phosphorylates the riboflavin (RF) precursor to FMN, and a FMN:adenylyltransferase (FMNAT) that transforms FMN into FAD. In most mammals two different monofunctional enzymes have each of these activities, but in prokaryotes a single bifunctional enzyme, FAD synthase (FADS), holds them. Differential structural and functional traits for RFK and FMNAT catalysis between bacteria and mammals, as well as within the few bacterial FADSs so far characterized, has envisaged the potentiality of FADSs from pathogens as targets for the development of species-specific inhibitors. Here, we particularly characterize the FADS from the ovine pathogen Brucella ovis (BoFADS), causative agent of brucellosis. We show that BoFADS has RFK activity independently of the media redox status, but its FMNAT activity (in both forward and reverse senses) only occurs under strong reducing conditions. Moreover, kinetics for flavin and adenine nucleotides binding to the RFK site show that BoFADS binds preferentially the substrates of the RFK reaction over the products and that the adenine nucleotide must bind prior to flavin entrapment. These results, together with multiple sequence alignments and phylogenetic analysis, point to variability in the less conserved regions as contributing to the species-specific features in prokaryotic FADSs, including those from pathogens, that allow them to adopt alternative strategies in FMN and FAD biosynthesis and overall flavin homeostasis.
Identifiants
pubmed: 34813144
doi: 10.1002/iub.2576
pmc: PMC9299109
doi:
Substances chimiques
Flavin-Adenine Dinucleotide
146-14-5
Flavin Mononucleotide
7N464URE7E
Nucleotidyltransferases
EC 2.7.7.-
FMN adenylyltransferase
EC 2.7.7.2
Riboflavin
TLM2976OFR
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
655-671Subventions
Organisme : Government of Aragón-FEDER
ID : E35_20R
Organisme : Spanish Ministry of Science and Innovation-State Research Agency
ID : PID2019-103901GB-I00
Informations de copyright
© 2021 The Authors. IUBMB Life published by Wiley Periodicals LLC on behalf of International Union of Biochemistry and Molecular Biology.
Références
Mol Biol Evol. 2018 Jun 1;35(6):1547-1549
pubmed: 29722887
Mol Syst Biol. 2011 Oct 11;7:539
pubmed: 21988835
PLoS One. 2019 Mar 22;14(3):e0213689
pubmed: 30901346
Sci Rep. 2017 Aug 8;7(1):7609
pubmed: 28790457
Sci Rep. 2017 Mar 24;7(1):404
pubmed: 28341845
Int J Mol Sci. 2020 May 25;21(10):
pubmed: 32466340
PLoS One. 2009;4(5):e5519
pubmed: 19436743
Nature. 2009 Aug 27;460(7259):1159-63
pubmed: 19641494
Crit Rev Microbiol. 2017 Mar;43(2):196-209
pubmed: 27822970
J Mol Biol. 2019 Jul 12;431(15):2762-2776
pubmed: 31132361
Nucleic Acids Res. 2016 Jul 8;44(W1):W344-50
pubmed: 27166375
J Mol Biol. 2010 Jul 9;400(2):218-30
pubmed: 20471397
PLoS One. 2015 May 04;10(5):e0126124
pubmed: 25938806
Front Microbiol. 2020 Dec 11;11:615860
pubmed: 33362753
FEBS J. 2011 Nov;278(22):4434-49
pubmed: 21951714
Int J Biol Macromol. 2019 Oct 1;138:986-995
pubmed: 31351152
Cell Biochem Biophys. 2013 Jan;65(1):57-68
pubmed: 22892871
Biochim Biophys Acta. 2015 Aug;1854(8):897-906
pubmed: 25801930
J Bacteriol. 2013 Sep;195(18):4037-45
pubmed: 23836860
Nat Prod Rep. 2013 Jan;30(1):175-200
pubmed: 23051833
J Bacteriol. 2016 Nov 4;198(23):3233-3243
pubmed: 27672192
FEBS Lett. 2014 Jan 31;588(3):414-21
pubmed: 24374335
J Biol Chem. 1979 Oct 10;254(19):9551-7
pubmed: 226520
J Nutr. 1983 Nov;113(11):2274-9
pubmed: 6138398
BMC Vet Res. 2015 May 30;11:125
pubmed: 26025374
Protein Sci. 2018 Jan;27(1):112-128
pubmed: 28836357
Mol Microbiol. 1996 Feb;19(4):803-13
pubmed: 8820650
Biochemistry. 2003 Nov 4;42(43):12532-8
pubmed: 14580199
J Enzyme Inhib Med Chem. 2018 Dec;33(1):842-849
pubmed: 29693467
Sci Rep. 2017 Aug 4;7(1):7281
pubmed: 28779158
FASEB J. 2020 Aug;34(8):10871-10886
pubmed: 32649804
PLoS Comput Biol. 2020 Aug 14;16(8):e1007898
pubmed: 32797038
Trends Biochem Sci. 2000 Mar;25(3):126-32
pubmed: 10694883
Mitochondrion. 2010 Apr;10(3):263-73
pubmed: 20060505
BMC Microbiol. 2008 Sep 23;8:160
pubmed: 18811972
IUBMB Life. 2022 Jul;74(7):655-671
pubmed: 34813144
Biochimie. 2021 Mar;182:217-227
pubmed: 33516756
Bioinformatics. 2009 Aug 1;25(15):1972-3
pubmed: 19505945
Acta Crystallogr D Biol Crystallogr. 2015 Dec 1;71(Pt 12):2526-42
pubmed: 26627660
Structure. 2003 Mar;11(3):265-73
pubmed: 12623014
Int J Oncol. 2011 Apr;38(4):893-902
pubmed: 21308351
Biophys J. 2018 Sep 18;115(6):988-995
pubmed: 30177440
FEBS J. 2011 Aug;278(15):2625-34
pubmed: 21635694
Nat Protoc. 2012 Jul 19;7(8):1511-22
pubmed: 22814390
Biochem Soc Trans. 2000;28(4):283-96
pubmed: 10961912
J Enzyme Inhib Med Chem. 2018 Dec;33(1):241-254
pubmed: 29258359
Int J Mol Sci. 2012 Nov 08;13(11):14492-517
pubmed: 23203077
Curr Pharm Des. 2013;19(14):2649-75
pubmed: 23116402
Int J Med Microbiol. 2019 May - Jun;309(3-4):225-231
pubmed: 31054808
Curr Opin Struct Biol. 2016 Dec;41:19-26
pubmed: 27266331